29-04-2025 18:04 via drugs.com

AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors

TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR) solid tumors, according to a study published online April 27 in the New...
Read more »

Pharmaceutical news



Milwaukee Closes More Schools to Address Lead Crisis
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
Statin Use Improves Outcomes in Chronic, Small Lymphocytic Leukemia
Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise
Adult Acne Linked to Higher Risk for Eating Disorders
Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
Antibiotic Exposure Before Age 2 May Increase Risk for Chronic Pediatric Conditions
New HHS Ad Campaign Urges Americans to 'Take Back Your Health'
Microbial Keratitis Outcomes Affected by Delays in Presentation, Disease Severity
Martinelli Recalls 170,000 Apple Juice Bottles for Possible Toxin
More Kids Without Asthma Inhaler After Popular Product Taken Off Market
Desktop versie